ArticleOncoimmunology2015

Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras.

Fuling Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.